Paratesticular Inflammatory Myofibroblastic Tumor in a Pediatric Patient

Although rare, paratesticular inflammatory myofibroblastic tumor (IMT) represents the second most common paratesticular mass after adenomatoid tumor and comprises roughly 6% of such lesions. Only approximately four cases have been reported in patients younger than 18 years of age. We report an incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Harel, Miriam, Makari, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036602/
https://www.ncbi.nlm.nih.gov/pubmed/24900936
http://dx.doi.org/10.1155/2014/303678
_version_ 1782318177445740544
author Harel, Miriam
Makari, John H.
author_facet Harel, Miriam
Makari, John H.
author_sort Harel, Miriam
collection PubMed
description Although rare, paratesticular inflammatory myofibroblastic tumor (IMT) represents the second most common paratesticular mass after adenomatoid tumor and comprises roughly 6% of such lesions. Only approximately four cases have been reported in patients younger than 18 years of age. We report an incidentally discovered paratesticular IMT in a 17-year-old male successfully treated with wide excision and testis sparing. To our knowledge, no recurrence has been reported after complete excision of paratesticular IMT; however, continued follow-up is recommended.
format Online
Article
Text
id pubmed-4036602
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40366022014-06-04 Paratesticular Inflammatory Myofibroblastic Tumor in a Pediatric Patient Harel, Miriam Makari, John H. Case Rep Urol Case Report Although rare, paratesticular inflammatory myofibroblastic tumor (IMT) represents the second most common paratesticular mass after adenomatoid tumor and comprises roughly 6% of such lesions. Only approximately four cases have been reported in patients younger than 18 years of age. We report an incidentally discovered paratesticular IMT in a 17-year-old male successfully treated with wide excision and testis sparing. To our knowledge, no recurrence has been reported after complete excision of paratesticular IMT; however, continued follow-up is recommended. Hindawi Publishing Corporation 2014 2014-05-12 /pmc/articles/PMC4036602/ /pubmed/24900936 http://dx.doi.org/10.1155/2014/303678 Text en Copyright © 2014 M. Harel and J. H. Makari. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Harel, Miriam
Makari, John H.
Paratesticular Inflammatory Myofibroblastic Tumor in a Pediatric Patient
title Paratesticular Inflammatory Myofibroblastic Tumor in a Pediatric Patient
title_full Paratesticular Inflammatory Myofibroblastic Tumor in a Pediatric Patient
title_fullStr Paratesticular Inflammatory Myofibroblastic Tumor in a Pediatric Patient
title_full_unstemmed Paratesticular Inflammatory Myofibroblastic Tumor in a Pediatric Patient
title_short Paratesticular Inflammatory Myofibroblastic Tumor in a Pediatric Patient
title_sort paratesticular inflammatory myofibroblastic tumor in a pediatric patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036602/
https://www.ncbi.nlm.nih.gov/pubmed/24900936
http://dx.doi.org/10.1155/2014/303678
work_keys_str_mv AT harelmiriam paratesticularinflammatorymyofibroblastictumorinapediatricpatient
AT makarijohnh paratesticularinflammatorymyofibroblastictumorinapediatricpatient

Ejemplares similares